Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Denmark
Clinical trial register · Denmark

Clinical Trials in Denmark

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2462 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:17 UTC
2462
Studies in scope
all four open statuses
1396
Recruiting now
open to new participants
446
Lead sponsors
across recruiting studies
Top sites
Copenhagen 2 Hvidovre 1 Rønne 1 Hillerød 1 Holbæk 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Copenhagen University Hospital, Rigshospitalet192 University of Aarhus189 Odense University Hospital101 Aarhus University Hospital75 AstraZeneca58 Merck Sharp & Dohme LLC49 University of Copenhagen47 Hoffmann-La Roche44 University of Southern Denmark41 Zealand University Hospital41 Aalborg University Hospital38 Novartis Pharmaceuticals36 Janssen Research & Development, LLC33 Herlev and Gentofte Hospital33 Novo Nordisk A/S32 Eli Lilly and Company32 Bispebjerg Hospital28 Aalborg University25 AbbVie25 Sanofi25 Steno Diabetes Center Copenhagen23 Nordsjaellands Hospital21 Bristol-Myers Squibb20 Copenhagen University Hospital, Hvidovre19 Hvidovre University Hospital19 Vejle Hospital18 Herlev Hospital18 Amgen18 Pfizer16 Bayer16 Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital15 University Hospital Bispebjerg and Frederiksberg15 Gødstrup Hospital15 Boehringer Ingelheim14 University Hospital, Gentofte, Copenhagen13 Esbjerg Hospital - University Hospital of Southern Denmark13 Genmab12 Abbott Medical Devices11 Incyte Corporation11 GlaxoSmithKline11 Tor Biering-Sørensen11 Danish Headache Center10 Copenhagen University Hospital at Herlev10 argenx9 Takeda9 Danish Research Centre for Magnetic Resonance9 Stichting Hemato-Oncologie voor Volwassenen Nederland8 European Organisation for Research and Treatment of Cancer - EORTC8 Zimmer Biomet8 Center for Clinical Research and Prevention7 Celgene7 Morten Hostrup, PhD7 Aarhus University Hospital Skejby7 Gustave Roussy, Cancer Campus, Grand Paris6 Princess Maxima Center for Pediatric Oncology6 Medtronic Cardiovascular6 University Hospital Schleswig-Holstein6 Martin Blomberg Jensen6 CSL Behring6 Copenhagen Studies on Asthma in Childhood6 Copenhagen Respiratory Research5 Regionshospital Nordjylland5 Glostrup University Hospital, Copenhagen5 Daiichi Sankyo5 Central Jutland Regional Hospital5 Alnylam Pharmaceuticals5 Population Health Research Institute5 Inna Chen, MD5 Vastra Gotaland Region5 Alexion Pharmaceuticals, Inc.5 Inge Marie Svane5 Susanne Dam Nielsen, MD, DMSc4 Danish Breast Cancer Cooperative Group4 Prehospital Center, Region Zealand4 Jørgen Bjerggaard Jensen4 Slagelse Hospital4 Medtronic4 Agios Pharmaceuticals, Inc.4 Boston Scientific Corporation4 Kolding Sygehus4 Ove Andersen4 W.L.Gore & Associates4 Genentech, Inc.4 Tesaro, Inc.4 Astellas Pharma Global Development, Inc.4 Oslo University Hospital4 Carsten Dirksen4 Blueprint Medicines Corporation3 Philips Clinical & Medical Affairs Global3 The Danish Center for Expertise in Rheumatology3 University Medical Center Groningen3 Lone Baandrup3 BeOne Medicines3 Coloplast A/S3 Amsterdam UMC, location VUmc3 Anders Fink-Jensen, MD, DMSci3 Copenhagen Academy for Medical Education and Simulation3 Spine Centre of Southern Denmark3 University College Copenhagen3 Tejs Ehlers Klug3 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3 St. Olavs Hospital3 Amager Hospital3 Naestved Hospital3 Genzyme, a Sanofi Company3 Merete Haedersdal3 Danish Dementia Research Centre3 Loxo Oncology, Inc.3 Bjorn H. Ebdrup3 Region Zealand3 Universitätsklinikum Hamburg-Eppendorf3 Caroline Michaela Kistorp3 Laura Ozer Kettner3 German CLL Study Group3 Charite University, Berlin, Germany3 UMC Utrecht3 Region of Southern Denmark3 Dianthus Therapeutics3 Central Denmark Region3 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company3 Biosense Webster, Inc.3 Nils Hoyer3 Thomas Engstrom3 Ethicon, Inc.2 Sahlgrenska University Hospital2 Turning Point Therapeutics, Inc.2 Northern Orthopaedic Division, Denmark2 Ulrik Lassen2 Ole De Backer2 Anteris Technologies Ltd.2 Klavs Würgler Hansen2 Immunovant Sciences GmbH2 University College of Northern Denmark2 Erasmus Medical Center2 Asger Lund, MD2 ML Bio Solutions, Inc.2 Peter Rossing2 CoreAalst BV2 European Myeloma Network B.V.2 Leiden University Medical Center2 Norwegian University of Science and Technology2 Rune Skovgaard Rasmussen2 Nicolai Jacob Wewer Albrechtsen2 Mirati Therapeutics Inc.2 Radiometer Medical ApS2 Ditte Hansen2 University Hospital, Antwerp2 University Hospital of North Norway2 Debiopharm International SA2 IO Biotech2 Nordic Society of Gynaecological Oncology - Clinical Trials Unit2 Vibeke Backer2 Pharming Technologies B.V.2 Insmed Incorporated2 Mats Heyman2 Claus Lindbjerg Andersen2 Ad scientiam2 Marius Henriksen2 Seagen, a wholly owned subsidiary of Pfizer2 Steen Hvitfeldt Poulsen2 Claus Bogh Juhl2 Kardigan, Inc.2 Andreas Munk Petersen2 Tampere University Hospital2 Lupin Ltd.2 Celldex Therapeutics2 Helena DOMINGUEZ2 Ascendis Pharma Growth Disorders A/S2 Mario Negri Institute for Pharmacological Research2 Ascendis Pharma A/S2 Ole Köhler-Forsberg2 Klaus Martiny2 BioNTech SE2 Region Örebro County2 Stemline Therapeutics, Inc.2 Karolinska Institutet2 Karyopharm Therapeutics Inc2 Eikon Therapeutics2 InnoCon Medical2 VectivBio AG2 Evald Hoej Christiansen2 Jimmi Nielsen2 Lars Wiuff Andersen2 Biohaven Therapeutics Ltd.2 Morten Ladekarl2 Ipsen2 UCB Biopharma SRL2 University of Birmingham2 Barbara Malene Fischer2 Institut de Recherches Internationales Servier2 Cytokinetics2 Tobias Todsen2 Kresten Krarup Keller2 United Therapeutics2 Region Skane2 Biogen2 Day One Biopharmaceuticals, Inc.2 Karen-Lise Garm Spindler2 Ferring Pharmaceuticals2 Gitte Fredberg Persson MD PhD2 Merz Therapeutics GmbH2 Ole Lander Svendsen2 Institut National de la Santé Et de la Recherche Médicale, France2 Niels Fristrup2 Leif Thuesen2 Uppsala University2 Avidity Biosciences, Inc.2 Eske Kvanner Aasvang2 King's College London2 Lone Skov2 University Hospital Muenster2 Psychiatric Research Unit, Region Zealand, Denmark2 Medical University of Vienna2 Regeneron Pharmaceuticals2 Istituto Giannina Gaslini2 Servier Bio-Innovation LLC2 Christian Hassager2 University of Calgary2 Grifols Therapeutics LLC2 Vertex Pharmaceuticals Incorporated2 Nordic Lymphoma Group2 Ionis Pharmaceuticals, Inc.2 Professor Klaus Bønnelykke2 Peter Humaidan2 Zenas BioPharma (USA), LLC2 Holbaek Sygehus2 Calcilytix Therapeutics, Inc., a BridgeBio company2 Acerta Pharma BV2 Regionshospitalet Silkeborg2 Eidos Therapeutics, a BridgeBio company2 BioInvent International AB2 ViiV Healthcare2 Soren Overgaard2 SynAct Pharma Aps2 Gitte Moos Knudsen2 Marianne Andersen2 Bo Feldt-Rasmussen2 Haukeland University Hospital2 Materialise2 Mette Hansen2 Kirsten Grønbæk2 Andreas Rosén Rasmussen1 Jesper James Linde1 The Leeds Teaching Hospitals NHS Trust1 Victoria Rosberg1 Stichting European Myeloma Network1 Mads Ryo Jochumsen1 Lise Aksglæde1 Janssen Pharmaceutica N.V., Belgium1 Xencor, Inc.1 Frederiksberg University Hospital1 Almirall, S.A.1 Peter Busch Østergren1 Pulmonx Corporation1 Danish Multiple Sclerosis Hospitals1 Tine Gregersen, MD1 Institut Investigacio Sanitaria Pere Virgili1 Acesion Pharma1 Kimie Bols Østergaard1 Anocca AB1 KeyBioscience AG1 Diagram B.V.1 Kyowa Kirin Pharmaceutical Development Ltd1 Claus Anders Bertelsen, PhD, MD1 Arvinas Inc.1 Soren Schou Olesen1 Rapamycin Holdings Inc.1 Arrowhead Pharmaceuticals1 Aleksander Krag1 Pomeranian Medical University Szczecin1 Rasmus Bo Hasselbalch1 Erasme University Hospital1 International CTEPH Association1 Helsinki University Central Hospital1 Angitia Incorporated Limited1 Daphne Kos1 Lars Vedel Kessing1 Medtronic MiniMed, Inc.1 Johannes Grand1 Ultragenyx Pharmaceutical Inc1 Michelle Baczynski1 RECORDATI GROUP1 Research Unit for General Practice in Aalborg1 Orion Corporation, Orion Pharma1 Acacia Pharma Ltd1 BACKBONE1 Jacob Christiansen Gandløse1 Theis S. Itenov1 Indiana University1 Y-mAbs Therapeutics1 Signe Torekov1 University Hospital, Ghent1 pharmaand GmbH1 Christina Kruuse1 Julie Gehl1 Christian Juhl Terkelsen1 Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Nedim Tojaga1 PedAL BCU, LLC1 Sahajanand Medical Technologies Limited1 Bioventus LLC1 Jeppe Lange1 Pär Johansson1 Fundació d'investigació Sanitària de les Illes Balears1 CarThera1 Centre Leon Berard1 Cancer Trials Ireland1 Chronic Obstructive Pulmonary Disease Trial Network, Denmark1 Bo Gregers Winkel1 InSightec1 Ulrikka Nygaard1 Lars Hvid1 Josefine Gradman1 Geron Corporation1 The European Forum for Research and Education in Allergy and Airway Diseases1 HerAccess ApS1 St. Anna Kinderkrebsforschung1 IRCCS San Raffaele1 Cyprus Institute of Neurology and Genetics1 Partner Therapeutics, Inc.1 Julie Midtgaard1 Regional Hospital West Jutland1 Intellia Therapeutics1 Associazione Italiana Ematologia Oncologia Pediatrica1 IDEAYA Biosciences1 Ribocure Pharmaceuticals AB1 Thomas Lund1 SecuraBio1 Christiane Marie Bourgin Folke Gam1 Olav Schjørring1 VDyne, Inc.1 Amicus Therapeutics1 Imperial College London1 University of Massachusetts, Worcester1 Copenhagen Trial Unit, Center for Clinical Intervention Research1 River 3 Renal Corp.1 Cook Research Incorporated1 Alimentiv Inc.1 Parker Research Institute1 Pia Jeppesen1 Anne Katrine Pagsberg1 University of Pittsburgh1 Jesper Kjaergaard1 Anders Perner1 Harmony Biosciences Management, Inc.1 Kristine Loessl1 VZW Cardiovascular Research Center Aalst1 Ryme Medical, Inc.1 Occlutech International AB1 Spark Therapeutics, Inc.1 Vibe G Frøkjær, MD, PhD1 TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)1 Aragon Pharmaceuticals, Inc.1 Bambino Gesù Hospital and Research Institute1 Danish Lung Cancer Group1 Kristian Karstoft1 Zimmer, GmbH1 Christian Liebst Frisk Toft1 Christian Mølgaard1 Micro Interventional Devices1 Molecure S.A.1 University College, London1 Peter Martin Hansen1 Hanmi Pharmaceutical Company Limited1 Cystotech1 Lund University Hospital1 Jesper Frank Christensen, PhD1 Celcuity Inc1 Jens D Hove, MD,PHD1 Ida Bruun Kristensen1 Actelion1 UNEEG Medical A/S1 Montreal Heart Institute1 Weill Medical College of Cornell University1 Biosensors Europe SA1 The University of Queensland1 Jakob Stokholm1 OncoZenge AB1 Longboard Pharmaceuticals1 University of Milano Bicocca1 Medical University of Graz1 Marie Luise Bisgaard, MD1 Michael Bau Mortensen1 Alumis Inc1 Olof Akre1 Medtronic - MITG1 Anne Juul Wikkelsø1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 University of Oxford1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Renaissance Pharma Ltd.1 Insel Gruppe AG, University Hospital Bern1 Invero Pharma, Inc.1 Deciphera Pharmaceuticals, LLC1 Universidad Complutense de Madrid1 Frank G. Holz1 Erling Oma1 Kirstine Kirkegaard1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Eisai Inc.1 Enlivex Therapeutics Ltd.1 Radboud University Medical Center1 Immunocore Ltd1 ETOP IBCSG Partners Foundation1 Niels Junker1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 Jakob Kristian Jakobsen1 Nowwell AS1 St. Antonius Hospital1 Gilead Sciences1 Thomas Decker Christensen1 Patrick Schjelderup1 Ludwig-Maximilians - University of Munich1 Jakob Stenman1 Philipp Dutkowski1 Christian Grønhøj Larsen1 Maria Lendorf1 Abdirahman Hassan Omar1 AriBio Co., Ltd.1 Poitiers University Hospital1 Vivet Therapeutics SAS1 Contura1 Sofie Folke1 North Estonia Medical Centre1 European Society of Cardiology1 Nikolai Albert1 Universitaire Ziekenhuizen KU Leuven1 Ulla Kampmann Opstrup1 Ole Frobert, MD, PhD1 Bettina Eiger1 Curasight1 Shionogi1 Ashkan Eftekhari1 Carsten Bogh Juhl1 Christian von Buchwald1 Mikkel Herly1 Åslaug Helland1 Henrik Nielsen1 Bolt Medical1 Nina Kimer1 Jens Rikardt Andersen1 Marianne Christina Klose1 Ismail Gögenur1 Heart Care Foundation1 AGO Study Group1 Brigitta Rasmussen Villumsen1 Kartos Therapeutics, Inc.1 Michael Mæng1 University of Cologne1 Anna Martling1 Gossamer Bio USA, Inc.1 Annexon, Inc.1 NHS Greater Glasgow and Clyde1 Matias Vested1 Peter Gaarsdal Uhrbrand1 Olfred Hansen1 Thomas Benfield1 University Hospital, Geneva1 Emergency Medical Services, Capital Region, Denmark1 Ditte Krag-Hansen1 Jazz Pharmaceuticals1 Ulla Feldt-Rasmussen1 Phillip Freeman1 Teva Branded Pharmaceutical Products R&D LLC1 Noema Pharma AG1 Viatris Innovation GmbH1 EMD Serono Research & Development Institute, Inc.1 St George's, University of London1 Scandinavian Critical Care Trials Group1 Chiesi Pharma AB, Nordic1 Arash Afshari1 NewAmsterdam Pharma1 Urovant Sciences GmbH1 Optheras AS1 Guri Hagberg1 Region MidtJylland Denmark1 Technical University of Denmark1 Johanne Smith-Nielsen1 Bo Biering-Soerensen1 Shanghai MicroPort Medical (Group) Co., Ltd.1 COMPASS Pathways1 Inotrem1 Maja Thiele1 Duke University1 MonTa Biosciences ApS1 Sitryx Therapeutics Ltd1 EBR Systems, Inc.1 Nessn Azawi1 Lea Nørgaard Sørensen1 H. Lundbeck A/S1 Institut universitaire de cardiologie et de pneumologie de Québec, University Laval1 Henrik Wiggers1 Contineum Therapeutics1 University of Thessaly1 Juan Luis Vásquez1 Revolution Medicines, Inc.1 MeiraGTx Ocular UK Ltd1 Verastem, Inc.1 Morten Steen Kvistholm Jensen1 Atamyo Therapeutics1 Jon Unosson1 Thomas Helleday Foundation1 Lars Rejnmark1 Laboratoires Thea1 Henning Bliddal1 Janssen-Cilag International NV1 Stereotaxis1 Tina Vilsbøll1 Calluna Pharma AS1 Montefiore Medical Center1 Cogent Biosciences, Inc.1 Theravance Biopharma1 Lars Peter Riber1 Malmö University1 The POLG Foundation1 MedImmune LLC1 oasicare ApS1 Xentria, Inc.1 CHDI Foundation, Inc.1 University of Rochester1 Eclipse Medical Ltd.1 Intuitive Surgical1 Kira Bloomquist1 Alentis Therapeutics AG1 Vitestro B.V.1 Anne Estrup Olesen1 Javier P. Gisbert1 Medtronic Neurovascular Clinical Affairs1 The Netherlands Cancer Institute1 Children's Fractures Interest Group, Denmark1 Claus Kjærgaard1 Danish Study Group1 Nuvalent Inc.1 Protara Therapeutics1 Ina Olmer Specht1 Kristian Kjær Petersen1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 Vico Therapeutics B. V.1 Region Västerbotten1 Malene Kjær Bruun1 Danish Gynecological Cancer Group1 Per Løgstrup Poulsen1 Vedanta Biosciences, Inc.1 Centre Hospitalier Universitaire Vaudois1 AquaTerapi1 SymBio Pharmaceuticals1 EuroBloodNet Association1 Arctic Therapeutics1 Anne Louise Tølbøll Sørensen1 Morten H. Bestle1 Nicholas Carlson1 Brigham and Women's Hospital1 Ellen Margrethe Hauge1 Sanofi Pasteur, a Sanofi Company1 Henrik Bo Wiberg Larsson1 TILT Biotherapeutics Ltd.1 Immunome, Inc.1 Akero Therapeutics, Inc1 University College Absalon1 Georgios Tsikandylakis, MD PhD1 University of L'Aquila1 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc1 Axel Brandes1 Iperboreal Pharma Srl1 PedNet Haemophilia Research Foundation1 Thomas Aagaard Rasmussen1 srdpiers1 Zealand Pharma1 Nobel Biocare1 Sven Löffeler1 NMD Pharma A/S1 Henry Smith1 ORNND - Operating Room Nurse Network Denmark1 Thomas Damgaard Sandahl1 AgNovos Healthcare, LLC1 Isabelle Opitz, Professor, MD1 Change Accelerator in Respiratory Care1 Anders Odgaard1 Catharina Ziekenhuis Eindhoven1 Memorial Sloan Kettering Cancer Center1 Rezolute1 Janssen-Cilag Ltd.1 Line Marker1 University of Minnesota1 SAb Biotherapeutics, Inc.1 Khondrion BV1 Dimerix Bioscience Pty Ltd1 RhoVac APS1 Per Ivarsen1 Camilla Balle1 Dyne Therapeutics1 Defactum, Central Denmark Region1 Britannia Pharmaceuticals Ltd.1 Horsens Hospital1 Klaus Fuglsang Kofoed1 Vividion Therapeutics, Inc.1 Ann-Sofie Backman1 AO Innovation Translation Center1 Lolland Community, Denmark1 Andreas Sjøholm-Christensen1 Fondation Hôpital Saint-Joseph1 Beyond Batten Disease Foundation1 MipSalus Aps1 Christoffer Johansen1 Annemette Lokkegaard1 VIVE - The Danish Center for Social Science Research1 Minervax ApS1 Edgewise Therapeutics, Inc.1 Henning Bundgaard1 Hanna Jangö1 Alliance for Clinical Trials in Oncology1 Louise Møldrup Nielsen1 Roche Diagnostics GmbH1 Anders Jørgensen1 CDR-Life AG1 Edwards Lifesciences1 Rikke Sorensen1 Jacob Bodilsen1 Relay Therapeutics, Inc.1 Galderma R&D1 GLSMED Learning Health S.A.1 University Hospital, Gasthuisberg1 AB Science1 Varian, a Siemens Healthineers Company1 Hamilton Health Sciences Corporation1 Pharmacosmos A/S1 Clear sponsor filter
Target enrolment
to

Trials in this register

3 of 2462 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)
NCT07518446Atrial Fibrillation (AF), Heart Failure, Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD)
Amager Hospital
Not applicable
2,800
Copenhagen
2024-09-01
Active, closed
REWRITALIZE Your Recovery - Evaluation of a Creative Writing Group Intervention
NCT06251908Schizophreniform Disorders, Bipolar Disorder, Severe Depression, Ptsd
Amager Hospital
Not applicable
300
Rønne, Copenhagen, Hillerød, Holbæk, Vordingborg
2024-02-12
Active, closed
Amager Hospital
Not applicable
30,000
Hvidovre
2020-11-01
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-denmark

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,462 studies in total at the last sync on 15 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Denmark?

1 of the 3 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 3 studies
PhaseStudiesRecruitingShare
Not applicable31100%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Amager Hospital31

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Pregnancy Loss, Early (1) Major Depression (1) Anxiety (1) Stress (Psychology) (1) Schizophreniform Disorders (1) Bipolar Disorder (1) Severe Depression (1) Ptsd (1) Atrial Fibrillation (AF) (1) Heart Failure (1) Asthma (Diagnosis) (1) Chronic Obstructive Pulmonary Disease (COPD) (1)
→

Browse trials by site location

Copenhagen (2) Hvidovre (1) Hillerød (1) Holbæk (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.